asked 45.2k views
4 votes
In europe, manufacturers of new drugs must submit a risk management plan (eu-rmp) with their application for licensing. how might this practice help protect public health.

asked
User Dolbz
by
8.2k points

1 Answer

3 votes
It is a regulatory document summitted to the health deparment each year or when they create new drugs.
answered
User Shanison
by
8.0k points
Welcome to Qamnty — a place to ask, share, and grow together. Join our community and get real answers from real people.